149 related articles for article (PubMed ID: 18443229)
1. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.
Jackson EK; Mi Z
Hypertension; 2008 Jun; 51(6):1637-42. PubMed ID: 18443229
[TBL] [Abstract][Full Text] [Related]
2. Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Tofovic DS; Bilan VP; Jackson EK
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):689-91. PubMed ID: 20374254
[TBL] [Abstract][Full Text] [Related]
3. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats.
Dubinion JH; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1330-6. PubMed ID: 16537795
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats.
Jackson EK; Zhang M; Liu W; Mi Z
J Pharmacol Exp Ther; 2007 Nov; 323(2):431-7. PubMed ID: 17726157
[TBL] [Abstract][Full Text] [Related]
5. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
Jackson EK; Mi Z; Tofovic SP; Gillespie DG
Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Jackson EK; Kochanek SJ; Gillespie DG
Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
[TBL] [Abstract][Full Text] [Related]
7. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
Zhu X; Gillespie DG; Jackson EK
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
[TBL] [Abstract][Full Text] [Related]
9. Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans.
Marney A; Kunchakarra S; Byrne L; Brown NJ
Hypertension; 2010 Oct; 56(4):728-33. PubMed ID: 20679179
[TBL] [Abstract][Full Text] [Related]
10. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
12. alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats.
Gao L; Zhu C; Jackson EK
J Pharmacol Exp Ther; 2003 May; 305(2):581-6. PubMed ID: 12606648
[TBL] [Abstract][Full Text] [Related]
13. Enhanced interaction between renovascular alpha(2)-adrenoceptors and angiotensin II receptors in genetic hypertension.
Jackson EK; Herzer WA; Kost CK; Vyas SJ
Hypertension; 2001 Sep; 38(3):353-60. PubMed ID: 11566904
[TBL] [Abstract][Full Text] [Related]
14. The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes.
Lee TI; Kao YH; Chen YC; Huang JH; Hsu MI; Chen YJ
Int J Cardiol; 2013 Oct; 168(6):5390-5. PubMed ID: 24012160
[TBL] [Abstract][Full Text] [Related]
15. Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.
Byku M; Macarthur H; Westfall TC
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2188-97. PubMed ID: 18835922
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress.
Liu L; Liu J; Tian XY; Wong WT; Lau CW; Xu A; Xu G; Ng CF; Yao X; Gao Y; Huang Y
Antioxid Redox Signal; 2014 Oct; 21(11):1571-81. PubMed ID: 24328731
[TBL] [Abstract][Full Text] [Related]
17. Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.
Devin JK; Pretorius M; Nian H; Yu C; Billings FT; Brown NJ
Hypertension; 2014 May; 63(5):951-7. PubMed ID: 24516103
[TBL] [Abstract][Full Text] [Related]
18. Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Khan MA; Abdullah NA; Johns EJ
Acta Physiol (Oxf); 2009 Mar; 195(3):397-404. PubMed ID: 19183357
[TBL] [Abstract][Full Text] [Related]
19. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
Vonend O; Okonek A; Stegbauer J; Habbel S; Quack I; Rump LC
Cardiovasc Res; 2005 May; 66(2):345-52. PubMed ID: 15820203
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
Malmström RE; Balmér KC; Weilitz J; Nordlander M; Sjölander M
Eur J Pharmacol; 2001 Apr; 418(1-2):95-104. PubMed ID: 11334870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
